[Inhibitory effect of alpha-2 adrenoceptor antagonist (DG-5128) on intractable asthma].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012129:Respiratory Function Tests
D000317:Adrenergic alpha-Antagonists; D007093:Imidazoles; C032368:midaglizole